Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 73 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


    February 2017
  2. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  3. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


    January 2017
  4. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


    November 2016
  5. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  6. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  7. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


    September 2016
  8. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  9. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  10. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


    August 2016
  11. KALMAN RS, Goldberg DS
    Obeticholic Acid Reduces Bacterial Translocation and Inhibits Intestinal Inflammation in Cirrhotic Rats.
    Gastroenterology. 2016 Aug 28. pii: S0016-5085(16)34977.
    PubMed     Text format    


  12. SARIN SK, Philips CA, Kamath PS, Choudhary A, et al
    Towards a Comprehensive New Classification of Portal Vein Thrombosis in Patients with Cirrhosis: A Commentary.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34975.
    PubMed     Text format    


    July 2016
  13. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  14. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    April 2016
  15. PALMER RH
    Biliary Cirrhosis Treated With Ursodeoxycholic Acid.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00363.
    PubMed     Text format    


  16. CALDERONE V, Gallego J, Fernandez-Miranda G, Garcia-Pras E, et al
    Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
    Gastroenterology. 2016;150:982-97.
    PubMed     Text format     Abstract available


    March 2016
  17. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  18. CHIN JL, Chan G, Ryan JD
    Noninvasive Assessment of Liver Fibrosis and Cirrhosis With Ultrasound-based Elastography in Alcohol-related Liver Disease.
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00301.
    PubMed     Text format    


  19. NEPHEW LD, Goldberg DS
    Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis.
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00377.
    PubMed     Text format    


  20. TAOULI B, Serfaty L
    Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:553-6.
    PubMed     Text format    


  21. IMAJO K, Kessoku T, Honda Y, Tomeno W, et al
    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Gastroenterology. 2016;150:626-637.
    PubMed     Text format     Abstract available


    February 2016
  22. BOYER TD, Sanyal AJ, Wong F, Frederick RT, et al
    Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1.
    Gastroenterology. 2016 Feb 16. pii: S0016-5085(16)00217.
    PubMed     Text format     Abstract available


    January 2016
  23. ABRALDES JG, Villanueva C, Aracil C, Turnes J, et al
    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00043.
    PubMed     Text format     Abstract available


  24. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  25. LIANGPUNSAKUL S, Crabb DW
    Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
    Gastroenterology. 2016;150:29-31.
    PubMed     Text format    


    November 2015
  26. MU X, Pradere JP, Affo S, Dapito DH, et al
    Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Gastroenterology. 2015 Nov 25. pii: S0016-5085(15)01721.
    PubMed     Text format     Abstract available


    October 2015
  27. WHITE DL, Richardson P, Tayoub N, Davila JA, et al
    The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2015 Oct 28. pii: S0016-5085(15)01435.
    PubMed     Text format    


  28. MOHANTY A, Tate J, Garcia-Tsao G
    Statins are Associated with a Decreased Risk of Decompensation and Death in Veterans with Hepatitis C-related Compensated Cirrhosis.
    Gastroenterology. 2015 Oct 17. pii: S0016-5085(15)01476.
    PubMed     Text format     Abstract available


  29. THIELE M, Detlefsen S, Sevelsted Moller L, Madsen BS, et al
    Transient and 2-dimensional Shear-Wave Elastography provide comparable assessment of Alcoholic Liver Fibrosis and Cirrhosis.
    Gastroenterology. 2015 Oct 1. pii: S0016-5085(15)01426.
    PubMed     Text format     Abstract available


  30. KOO JH, Lee HJ, Kim W, Kim SG, et al
    Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-mediated Degradation of HNRNPA1 and Upregulation of SMAD2.
    Gastroenterology. 2015 Oct 1. pii: S0016-5085(15)01425.
    PubMed     Text format     Abstract available


    September 2015
  31. BAJAJ JS
    Diagnosing Minimal Hepatic Encephalopathy: From the Ivory Tower to the Real World.
    Gastroenterology. 2015 Sep 25. pii: S0016-5085(15)01384.
    PubMed     Text format    


  32. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.
    Gastroenterology. 2015 Sep 15. pii: S0016-5085(15)01199.
    PubMed     Text format    


  33. GARCIA-PAGAN JC, Patch D
    Trials and Tribulations: The Prevention of Variceal Rebleeding.
    Gastroenterology. 2015;149:528-31.
    PubMed     Text format    


  34. DU PLESSIS J, van Pelt J, Korf H, Mathieu C, et al
    Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2015;149:635-48.
    PubMed     Text format     Abstract available


  35. XANTHAKOS SA, Jenkins TM, Kleiner DE, Boyce TW, et al
    High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
    Gastroenterology. 2015;149:623-34.
    PubMed     Text format     Abstract available


    August 2015
  36. AMPUERO J, Simon M, Montoliu C, Jover R, et al
    Minimal Hepatic Encephalopathy and Critical Flicker Frequency are Associated With Survival of Patients With Cirrhosis.
    Gastroenterology. 2015 Aug 20. pii: S0016-5085(15)01176.
    PubMed     Text format     Abstract available


  37. LOOMBA R, Schork N, Chen CH, Bettencourt R, et al
    Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.
    Gastroenterology. 2015 Aug 20. pii: S0016-5085(15)01179.
    PubMed     Text format     Abstract available


  38. LAMMERS WJ, Hirschfield GM, Corpechot C, Nevens F, et al
    Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Gastroenterology. 2015 Aug 7. pii: S0016-5085(15)01094.
    PubMed     Text format     Abstract available


  39. BESTE LA, Leipertz SL, Green PK, Dominitz JA, et al
    Trends in the burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans from 2001-2013.
    Gastroenterology. 2015 Aug 5. pii: S0016-5085(15)01088.
    PubMed     Text format     Abstract available


  40. FOSTER GR, Pianko S, Brown A, Forton D, et al
    Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-alfa in Patients With HCV Genotype 3 Infection and Treatment-Experienced Patients with Cirrhosis and HCV Genotype 2 Infection.
    Gastroenterology. 2015 Aug 3. pii: S0016-5085(15)01069.
    PubMed     Text format     Abstract available


  41. HIRSCHFIELD GM
    Reply.
    Gastroenterology. 2015;149:508-9.
    PubMed     Text format    


  42. LOOMBA R, Chalasani N
    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.
    Gastroenterology. 2015;149:278-81.
    PubMed     Text format    


  43. ANGULO P, Kleiner DE, Dam-Larsen S, Adams LA, et al
    Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2015;149:389-97.
    PubMed     Text format     Abstract available


    July 2015
  44. MEHTA A, Singal AG
    Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
    Gastroenterology. 2015 Jul 28. pii: S0016-5085(15)01012.
    PubMed     Text format    


  45. KOFF RS
    Cirrhosis: A Practical Guide to Management.
    Gastroenterology. 2015 Jul 25. pii: S0016-5085(15)01011.
    PubMed     Text format    


  46. LAWITZ E, Makara M, Akarca US, Thuluvath PJ, et al
    Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-label Study of Patients With Genotype 1b Chronic Hepatitis C Virus, With and Without Cirrhosis.
    Gastroenterology. 2015 Jul 10. pii: S0016-5085(15)00936.
    PubMed     Text format     Abstract available


    June 2015
  47. DONG R, Zheng S, Chen G
    The Appropriate Timing and Dose of Obeticholic Acid in Patients With Primary Biliary Cirrhosis.
    Gastroenterology. 2015 Jun 29. pii: S0016-5085(15)00864.
    PubMed     Text format    


    May 2015
  48. SAUERBRUCH T, Mengel M, Dollinger M, Zipprich A, et al
    Prevention of Rebleeding from Esophageal Varices in Patients with Cirrhosis Receiving Small-diameter Stents vs Hemodynamically Controlled Medical Therapy.
    Gastroenterology. 2015 May 16. pii: S0016-5085(15)00683.
    PubMed     Text format     Abstract available


  49. CHARLTON M, Everson GT, Flamm SL, Kumar P, et al
    Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients with Advanced Liver Disease.
    Gastroenterology. 2015 May 15. pii: S0016-5085(15)00682.
    PubMed     Text format     Abstract available


    April 2015
  50. BETTAIEB A, Jiang JX, Sasaki Y, Chao TI, et al
    Hepatocyte NADPH Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
    Gastroenterology. 2015 Apr 14. pii: S0016-5085(15)00509.
    PubMed     Text format     Abstract available


  51. LAMMERS WJ, van Buuren HR, Hirschfield GM, Hansen BE, et al
    Reply: To PMID 25160979.
    Gastroenterology. 2015;148:860-1.
    PubMed     Text format    


  52. NEUSCHWANDER-TETRI BA
    Targeting the FXR nuclear receptor to treat liver disease.
    Gastroenterology. 2015;148:704-6.
    PubMed     Text format    


    March 2015
  53. KANWAL F
    Decreasing mortality in patients hospitalized with cirrhosis.
    Gastroenterology. 2015 Mar 21. pii: S0016-5085(15)00379.
    PubMed     Text format    


  54. KEDARISETTY CK, Anand L, Bhardwaj A, Bhadoria AS, et al
    Combination of Granulocyte Colony-Stimulating Factor and Erythropoietin Improves Outcomes of Patients with Decompensated Cirrhosis.
    Gastroenterology. 2015 Mar 4. pii: S0016-5085(15)00304.
    PubMed     Text format     Abstract available


  55. BERNSMEIER C, Pop OT, Singanayagam A, Triantafyllou E, et al
    Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
    Gastroenterology. 2015;148:603-615.
    PubMed     Text format     Abstract available


    February 2015
  56. GILJACA V, Stimac D, Gluud C
    Levels of Alkaline Phosphatase and Bilirubin Are Surrogate Endpoints of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study.
    Gastroenterology. 2015 Feb 26. pii: S0016-5085(15)00167.
    PubMed     Text format    


    January 2015
  57. SCHMIDT M, Barritt AS, Orman ES, Hayashi PH, et al
    Decreasing Mortality Among Patients Hospitalized with Cirrhosis in the United States From 2002 through 2010.
    Gastroenterology. 2015 Jan 23. pii: S0016-5085(15)00117.
    PubMed     Text format     Abstract available


  58. AGHEMO A, Donato MF
    Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.
    Gastroenterology. 2015;148:13-6.
    PubMed     Text format    


    December 2014
  59. PEARLMAN BL, Ehleben C, Perrys M
    The Combination of Simeprevir and Sofosbuvir is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients with Hepatitis C-related Child's Class A Cirrhosis.
    Gastroenterology. 2014 Dec 31. pii: S0016-5085(14)01579.
    PubMed     Text format     Abstract available


  60. HIRSCHFIELD GM, Mason A, Luketic V, Lindor K, et al
    Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid.
    Gastroenterology. 2014 Dec 11. pii: S0016-5085(14)01530.
    PubMed     Text format     Abstract available


  61. DHIMAN RK, Rana B, Agrawal S, Garg A, et al
    Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial.
    Gastroenterology. 2014;147:1327-1337.
    PubMed     Text format     Abstract available


  62. KANWAL F, Volk M, Singal A, Angeli P, et al
    Improving quality of health care for patients with cirrhosis.
    Gastroenterology. 2014;147:1204-7.
    PubMed     Text format    


  63. TACKE F
    Reply: To PMID 24481979.
    Gastroenterology. 2014;147:1431.
    PubMed     Text format    


  64. DRANOFF JA
    Macrophage heterogeneity in liver injury: you are now leaving Kupffertown.
    Gastroenterology. 2014;147:1430-1.
    PubMed     Text format    


  65. VICTOR DW 3RD, Quigley EM
    Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis.
    Gastroenterology. 2014;147:1216-8.
    PubMed     Text format    


    October 2014
  66. GANDHI CR, Chaillet JR, Nalesnik MA, Kumar S, et al
    Liver-specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice.
    Gastroenterology. 2014 Oct 13. pii: S0016-5085(14)01207.
    PubMed     Text format     Abstract available


  67. CHARLTON M, Gane E, Manns MP, Brown RS Jr, et al
    Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation.
    Gastroenterology. 2014 Oct 7. pii: S0016-5085(14)01194.
    PubMed     Text format     Abstract available


  68. MANDORFER M, Peck-Radosavljevic M, Reiberger T
    Reply: To PMID 24631577.
    Gastroenterology. 2014;147:942.
    PubMed     Text format    


  69. MOURAD A, Mathurin P, Deuffic-Burban S
    Reply: To PMID 24677195.
    Gastroenterology. 2014;147:936-7.
    PubMed     Text format    


    September 2014
  70. FERREIRA AO, Marinho RT
    Risky Business - the Real Life of the Unresolved HCV Therapy.
    Gastroenterology. 2014 Sep 25. pii: S0016-5085(14)01086.
    PubMed     Text format    


  71. CURRY MP, Forns X, Chung RT, Terrault NA, et al
    Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection after Liver Transplantation: An Open-Label Study.
    Gastroenterology. 2014 Sep 24. pii: S0016-5085(14)01145.
    PubMed     Text format     Abstract available


    August 2014
  72. YOSHIDA S, Ikenaga N, Liu SB, Peng ZW, et al
    Extra-hepatic PDGFB, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice.
    Gastroenterology. 2014 Aug 27. pii: S0016-5085(14)01077.
    PubMed     Text format     Abstract available


    July 2014
  73. FISHER FM, Chui PC, Nasser IA, Popov Y, et al
    Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-deficient Diets.
    Gastroenterology. 2014 Jul 29. pii: S0016-5085(14)00969.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: